Kalscheuer H, Seufert J, Lanzinger S et al (2019) Event rates and risk factors for the development of diabetic ketoacidosis in adult patients with type 1 diabetes: analysis from the DPV registry based on 46,966 patients
The integration of AI and ML in transdermal drug delivery could be the next breakthrough, as it can predict drug entrapment with a 93% accuracy and improve formulation by forecasting drug release kinetics, stability, and skin penetration
& Girardi, A
The full effects of Semaglutide GLP-1 take time to develop, and results vary depending on individual factors
Originally approved for diabetes, GLP-1 drugs are positively used in the management of weight loss, cardiovascular risk, fatty liver disease, and neurodegenerative conditions
Occasional light-headedness after a shot Tip: Have a balanced snack within an hour of injecting and stay well-hydrated, especially on workout days